BioNTech is buying into one of the hottest areas of oncology, agreeing to pay $800 million to acquire China-based Biotheus ...

Not to be confused with the theme park attraction Disney's Hollywood Studios. Eisner, Disney's then-chief, intended Hollywood Pictures to be a full-fledged studio, like Touchstone, but in its later ...

The new images reveal the shockwaves generated by these stellar eruptions, which began with an explosive star collapse that was visible to astronomers on Earth nearly 1,000 years ago. Peering deep ...

For example, you can snap a picture of your kid on your phone and send it to grandma's digital photo frame instantly over the cloud. Every option in this guide has been tested for picture quality ...

in combination with Keytruda, Merck’s anti-PD-1 therapy, as adjuvant treatment for patients with resectable Stage II, IIIA or IIIB non-small cell lung cancer who did not achieve a pathological ...

The INTerpath-009 trial will investigate an individualized neoantigen therapy plus Keytruda in patients with non-small cell lung cancer post-surgery whose disease didn't fully respond to prior ...

NEW YORK – Moderna and Merck will test their personalized neoantigen cancer vaccine V940 with Merck's checkpoint inhibitor Keytruda (pembrolizumab) in certain non-small cell lung cancer patients in a ...

The "diagnostic assistant," as Aerts calls it, provides a point-of-care test using the newest technology, allowing HCPs who suspect a patient has leprosy to take a picture of the patient’s skin ...

We've rounded up the best cameras for photos and videos. Research ahead of Black Friday and use one this month to capture the Northern Lights or the Taurid meteor shower. The best cameras are a ...

Alright, alright, alright! Matthew McConaughey has dropped his pants to celebrate the first birthday of his tequila brand, Pantalones – and his 55th birthday. To celebrate, Matthew was joined ...

KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless ...

KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless of ...